AnaptysBio reports phase II interim data on ANB-019 in generalized pustular psoriasis Oct. 1, 2019 No Comments
Pfizer announces topline results from pivotal JADE MONO-2 study of abrocitinib Sep. 30, 2019 No Comments
First patient dosed in phase III TRuE-V clinical trial program of ruxolitinib cream Sep. 26, 2019 No Comments
Phase III study of StrataGraft regenerative tissue meets both primary endpoints Sep. 25, 2019 No Comments
Bristol-Myers Squibb designs RORgammaT inverse agonists showing biologic-like efficacy Sep. 9, 2019 No Comments
Krystal Biotech initiates phase I/II study of topical KB-105 gene therapy for TGM1-deficient ARCI Sep. 2, 2019 No Comments
Phase III BREEZE-AD7 study of baricitinib in atopic dermatitis meets primary endpoint Aug. 26, 2019 No Comments
RSS